Gold Nanorod/Titanium Dioxide Hybrid Nanoparticles for Plasmon-Enhanced Near-Infrared Photoproduction of Hydroxyl Radicals and Photodynamic Therapy.

Gold nanoparticles, such as nanorods (AuNRs), present exceptionally high absorption cross sections that can be tuned to the near-infrared (NIR), the optimal window for light penetration in biological tissues. This makes them valuable photosensitizers for the treatment of cancer using photothermal therapy, where absorbed light energy is converted into heat. In addition, there is a strong interest in using hot electron carriers generated in AuNRs by NIR irradiation to produce cytotoxic radical oxygen species in order to enhance the efficiency of the phototherapy. Here, we show that hybrid nanoparticles composed of AuNRs with TiO2 deposited at their extremities are efficient sensitizers to produce hydroxyl radical species under NIR irradiation. We attribute this phenomenon to the transfer of hot electrons generated from the plasmon excitation in AuNR to the TiO2 tips, followed by reduction of dioxygen. We then functionalize these hybrid AuNR/TiO2 nanoparticles with block poly(ethylene glycol)-phosphonate polymer ligands to stabilize them in a physiological medium. We finally demonstrate that the photodynamic effect induces cell death upon irradiation with a greater efficiency than the photothermal effect alone.

Designing the Surface Chemistry of Inorganic Nanocrystals for Cancer Imaging and Therapy.

Inorganic nanocrystals, such as gold, iron oxide and semiconductor quantum dots, offer promising prospects for cancer diagnostics, imaging and therapy, due to their specific plasmonic, magnetic or fluorescent properties. The organic coating, or surface ligands, of these nanoparticles ensures their colloidal stability in complex biological fluids and enables their functionalization with targeting functions. It also controls the interactions of the nanoparticle with biomolecules in their environment. It therefore plays a crucial role in determining nanoparticle biodistribution and, ultimately, the imaging or therapeutic efficiency. This review summarizes the various strategies used to develop optimal surface chemistries for the in vivo preclinical and clinical application of inorganic nanocrystals. It discusses the current understanding of the influence of the nanoparticle surface chemistry on its colloidal stability, interaction with proteins, biodistribution and tumor uptake, and the requirements to develop an optimal surface chemistry.